Ghrelin and its role in gastrointestinal tract tumors (Review)
- Authors:
- Irene Alexandra Spiridon
- Delia Gabriela Apostol Ciobanu
- Simona Eliza Giușcă
- Irina Draga Căruntu
-
Affiliations: Department of Pathology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, Iași 700115, Romania, Department of Histology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, Iași 700115, Romania - Published online on: July 19, 2021 https://doi.org/10.3892/mmr.2021.12302
- Article Number: 663
-
Copyright: © Spiridon et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656–660. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Stengel A, Goebel M, Wang L and Taché Y: Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: Role as regulators of food intake and body weight. Peptides. 31:357–369. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Davis EA, Wald HS, Suarez AN, Zubcevic J, Liu CM, Cortella AM, Kamitakahara AK, Polson JW, Arnold M, Grill HJ, et al: Ghrelin signaling affects feeding behavior, metabolism, and memory through the vagus nerve. Curr Biol. 30:4510–4518.e6. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, et al: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 37:649–661. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA and Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86:59922001. View Article : Google Scholar : PubMed/NCBI | |
|
Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M and Kangawa K: Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 276:905–908. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Carlini VP, Monzón ME, Varas MM, Cragnolini AB, Schiöth HB, Scimonelli TN and de Barioglio SR: Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun. 299:739–743. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Steiger A: Ghrelin and sleep-wake regulation. Am J Physiol Regul Integr Comp Physiol. 292:R573–R574. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Engevik AC, Kaji I and Goldenring JR: The physiology of the gastric parietal cell. Physiol Rev. 100:573–602. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Korbonits M, Kojima M, Kangawa K and Grossman AB: Presence of ghrelin in normal and adenomatous human pituitary. Endocrine. 14:101–104. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Papotti M, Duregon E and Volante M: Ghrelin and tumors. Endocr Dev. 25:122–134. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kojima M and Kangawa K: Ghrelin: Structure and function. Physiol Rev. 85:495–522. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fakhry J, Stebbing MJ, Hunne B, Bayguinov Y, Ward SM, Sasse KC, Callaghan B, McQuade RM and Furness JB: Relationships of endocrine cells to each other and to other cell types in the human gastric fundus and corpus. Cell Tissue Res. 376:37–49. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gribble FM and Reimann F: Enteroendocrine cells: Chemosensors in the intestinal epithelium. Annu Rev Physiol. 78:277–299. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Choi E, Roland JT, Barlow BJ, O'Neal R, Rich AE, Nam KT, Shi C and Goldenring JR: Cell lineage distribution atlas of the human stomach reveals heterogeneous gland populations in the gastric antrum. Gut. 63:1711–1720. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sykaras AG, Demenis C, Cheng L, Pisitkun T, Mclaughlin JT, Fenton RA and Smith CP: Duodenal CCK cells from male mice express multiple hormones including ghrelin. Endocrinology. 155:3339–3351. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Reynaud Y, Fakhry J, Fothergill L, Callaghan B, Ringuet M, Hunne B, Bravo DM and Furness JB: The chemical coding of 5-hydroxytryptamine containing enteroendocrine cells in the mouse gastrointestinal tract. Cell Tissue Res. 364:489–449. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fothergill LJ, Callaghan B, Hunne B, Bravo DM and Furness JB: Costorage of enteroendocrine hormones evaluated at the cell and subcellular levels in male mice. Endocrinology. 158:2113–2123. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Glass LL, Calero-Nieto FJ, Jawaid W, Larraufie P, Kay RG, Göttgens B, Reimann F and Gribble FM: Single-cell RNA-sequencing reveals a distinct population of proglucagon-expressing cells specific to the mouse upper small intestine. Mol Metab. 6:1296–1303. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fothergill LJ and Furness JB: Diversity of enteroendocrine cells investigated at cellular and subcellular levels: The need for a new classification scheme. Histochem Cell Biol. 150:693–702. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Grönberg M, Tsolakis AV, Magnusson L, Janson ET and Saras J: Distribution of obestatin and ghrelin in human tissues: Immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem. 56:793–801. 2008. View Article : Google Scholar | |
|
Zhao Z and Sakai T: Characteristic features of ghrelin cells in the gastrointestinal tract and the regulation of stomach ghrelin expression and production. World J Gastroenterol. 14:6306–6311. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Teive MB, Russi RF, Vieira DS, Teive AM, Costa A and d'Acampora AJ: Quantitative immunohistochemical analysis of duodenal ghrelin cells after sleeve gastrectomy in Wistar rats. Acta Cir Bras. 27:595–599. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mehdar KM: The distribution of ghrelin cells in the human and animal gastrointestinal tract: A review of the evidence. Folia Morphol (Warsz). 80:225–236. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB and Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 87:29882002. View Article : Google Scholar : PubMed/NCBI | |
|
Santos M, Bastos P, Gonzaga S, Roriz JM, Baptista MJ, Nogueira-Silva C, Melo-Rocha G, Henriques-Coelho T, Roncon-Albuquerque R Jr, Leite-Moreira AF, et al: Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia. Pediatr Res. 59:531–537. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, Herington AC and Chopin LK: Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer. 12:839–850. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yeh AH, Jeffery PL, Duncan RP, Herington AC and Chopin LK: Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res. 11:8295–8303. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K and Kojima M: Structure, regulation and function of ghrelin. J Biochem. 151:119–128. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C and Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 310:996–999. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Nishi Y, Yoh J, Hiejima H and Kojima M: Structures and molecular forms of the ghrelin-family peptides. Peptides. 32:2175–2182. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hosoda H, Kojima M, Mizushima T, Shimizu S and Kangawa K: Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem. 278:64–70. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Pemberton C, Wimalasena P, Yandle T, Soule S and Richards M: C-terminal pro-ghrelin peptides are present in the human circulation. Biochem Biophys Res Commun. 310:567–573. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F and Kangawa K: Optimum collection and storage conditions for ghrelin measurements: Octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem. 50:1077–1080. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Patterson M, Murphy KG, le Roux CW, Ghatei MA and Bloom SR: Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab. 90:2205–2211. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ibrahim Abdalla MM: Ghrelin-physiological functions and regulation. Eur Endocrinol. 11:90–95. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Delhanty PJ, Neggers SJ and van der Lely AJ: Mechanisms in endocrinology: Ghrelin: The differences between acyl- and des-acyl ghrelin. Eur J Endocrino. 167:601–608. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lanfranco F, Baldi M, Cassoni P, Bosco M, Ghé C and Muccioli G: Ghrelin and prostate cancer. Vitam Horm. 77:301–324. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gahete MD, Córdoba-Chacón J, Hergueta-Redondo M, Martínez-Fuentes AJ, Kineman RD, Moreno-Bueno G, Luque RM and Castaño JP: A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: Potential pathophysiological relevance. PLoS One. 6:e233022011. View Article : Google Scholar : PubMed/NCBI | |
|
Gahete MD, Rincón-Fernández D, Villa-Osaba A, Hormaechea-Agulla D, Ibáñez-Costa A, Martínez-Fuentes AJ, Gracia-Navarro F, Castaño JP and Luque RM: Ghrelin gene products, receptors, and GOAT enzyme: Biological and pathophysiological insight. J Endocrinol. 220:R1–R24. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Brown MS, Liang G, Grishin NV and Goldstein JL: Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 132:387–396. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Delporte C: Structure and physiological actions of ghrelin. Scientifica (Cairo). 2013:5189092013.PubMed/NCBI | |
|
Ferré G, Louet M, Saurel O, Delort B, Czaplicki G, M'Kadmi C, Damian M, Renault P, Cantel S, Gavara L, et al: Structure and dynamics of G protein-coupled receptor-bound ghrelin reveal the critical role of the octanoyl chain. Proc Natl Acad Sci USA. 116:17525–17530. 2019. View Article : Google Scholar | |
|
Rodríguez A, Gómez-Ambrosi J, Catalán V, Gil MJ, Becerril S, Sáinz N, Silva C, Salvador J, Colina I and Frühbeck G: Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond). 33:541–552. 2009. View Article : Google Scholar | |
|
Heppner KM, Piechowski CL, Müller A, Ottaway N, Sisley S, Smiley DL, Habegger KM, Pfluger PT, Dimarchi R, Biebermann H, et al: Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes. 63:122–131. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974–977. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Volante M, Fulcheri E, Allìa E, Cerrato M, Pucci A and Papotti M: Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem. 50:1013–1021. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Muccioli G, Baragli A, Granata R, Papotti M and Ghigo E: Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology. 86:147–164. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ueberberg B, Unger N, Saeger W, Mann K and Petersenn S: Expression of ghrelin and its receptor in human tissues. Horm Metab Res. 41:814–821. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao X, Bi M, Jiao Q, Chen X, Du X and Jiang H: A new understanding of GHSR1a-independent of ghrelin activation. Ageing Res Rev. 64:1011872020. View Article : Google Scholar : PubMed/NCBI | |
|
Albarrán-Zeckler RG and Smith RG: The ghrelin receptors (GHS-R1a and GHS-R1b). Endocr Dev. 25:5–15. 2013. View Article : Google Scholar | |
|
Callaghan B and Furness JB: Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds. Pharmacol Rev. 66:984–1001. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Drucker DJ: Evolving concepts and translational relevance of enteroendocrine cell biology. J Clin Endocrinol Metab. 101:778–786. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC and Wells T: Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 145:234–242. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Churm R, Davies JS, Stephens JW and Prior SL: Ghrelin function in human obesity and type 2 diabetes: A concise review. Obes Rev. 18:140–148. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, et al: Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology. 147:2306–2314. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Au CC, Furness JB and Brown KA: Ghrelin and breast cancer: Emerging roles in obesity, estrogen regulation, and cancer. Front Oncol. 6:2652017. View Article : Google Scholar : PubMed/NCBI | |
|
Rodríguez A, Gómez-Ambrosi J, Catalán V, Rotellar F, Valentí V, Silva C, Mugueta C, Pulido MR, Vázquez R, Salvador J, et al: The ghrelin O-acyltransferase-ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia. 55:3038–3050. 2012. View Article : Google Scholar | |
|
Sheriff S, Kadeer N, Joshi R, Friend LA, James JH and Balasubramaniam A: Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol Cell Endocrinol. 351:286–295. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wu R, Chaung WW, Dong W, Ji Y, Barrera R, Nicastro J, Molmenti EP, Coppa GF and Wang P: Ghrelin maintains the cardiovascular stability in severe sepsis. J Surg Res. 178:370–377. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Porporato PE, Filigheddu N, Reano S, Ferrara M, Angelino E, Gnocchi VF, Prodam F, Ronchi G, Fagoonee S, Fornaro M, et al: Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest. 123:611–622. 2013.PubMed/NCBI | |
|
Bouillon-Minois JB, Trousselard M, Thivel D, Gordon BA, Schmidt J, Moustafa F, Oris C and Dutheil F: Ghrelin as a biomarker of stress: A systematic review and meta-analysis. Nutrients. 13:7842021. View Article : Google Scholar : PubMed/NCBI | |
|
Gray SM, Page LC and Tong J: Ghrelin regulation of glucose metabolism. J Neuroendocrinol. 31:e127052019. View Article : Google Scholar : PubMed/NCBI | |
|
Nass RM, Gaylinn BD, Rogol AD and Thorner MO: Ghrelin and growth hormone: Story in reverse. Proc Natl Acad Sci USA. 107:8501–8502. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Quiñones M, Fernø J and Al-Massadi O: Ghrelin and liver disease. Rev Endocr Metab Disord. 21:45–56. 2020. View Article : Google Scholar | |
|
Akalu Y, Molla MD, Dessie G and Ayelign B: Physiological effect of ghrelin on body systems. Int J Endocrinol. 2020:13851382020. View Article : Google Scholar : PubMed/NCBI | |
|
Tschöp M, Smiley DL and Heiman ML: Ghrelin induces adiposity in rodents. Nature. 407:908–913. 2000. View Article : Google Scholar | |
|
Mihalache L, Arhire LI, Giuşcă SE, Gherasim A, Niţă O, Constantinescu D, Constantinescu RN, Pădureanu SS and Danciu M: Ghrelin-producing cells distribution in the stomach and the relation with Helicobacter pylori in obese patients. Rom J Morphol Embryol. 60:219–225. 2019.PubMed/NCBI | |
|
Chowen JA and Argente J: Ghrelin: A link between energy homeostasis and the immune system. Endocrinology. 158:2077–2081. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr and Taub DD: Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kasımay O, Işeri SO, Barlas A, Bangir D, Yeğen C, Arbak S and Yeğen BC: Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol Res. 36:11–19. 2006. View Article : Google Scholar | |
|
Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, Li HT and Wang T: Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides. 30:2286–2291. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chang RJ, Wang HL, Qin MB, Liang ZH, He JP, Wei YL, Fu HZ and Tang GD: Ghrelin inhibits IKKβ/NF-κB activation and reduces pro-inflammatory cytokine production in pancreatic acinar AR42J cells treated with cerulein. Hepatobiliary Pancreat Dis Int. Jun 2–2020.(Online ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Mao Y, Wang J, Yu F, Cheng J, Li H, Guo C and Fan X: Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice. Drug Des Devel Ther. 9:5385–5396. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T and Kouroumalis EA: Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 12:100–105. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H, Theil J, von Hörsten S, Yokote H, Chiba A, et al: Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol. 183:2859–2866. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Granado M, Priego T, Martín AI, Villanúa MA and López-Calderón A: Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 288:E486–E492. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Gonzalez-Rey E, Chorny A and Delgado M: Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 130:1707–1720. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Luo J, Guillory B, Chen JA, Zang P, Yoeli JK, Hernandez Y, Lee II, Anderson B, Storie M, et al: Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways. Oncotarget. 11:3286–3302. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lacerda-Miranda G, Soares VM, Vieira AK, Lessa JG, Rodrigues-Cunha AC, Cortez E, Garcia-Souza EP and Moura AS: Ghrelin signaling in heart remodeling of adult obese mice. Peptides. 35:65–73. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sullivan R, McGirr R, Hu S, Tan A, Wu D, Charron C, Lalonde T, Arany E, Chakrabarti S, Luyt L and Dhanvantari S: Changes in the cardiac GHSR1a-ghrelin system correlate with myocardial dysfunction in diabetic cardiomyopathy in mice. J Endocr Soc. 2:178–189. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Grossini E, Raina G, Farruggio S, Camillo L, Molinari C, Mary D, Walker GE, Bona G, Vacca G, Moia S, et al: Intracoronary des-acyl ghrelin acutely increases cardiac perfusion through a nitric oxide-related mechanism in female anesthetized pigs. Endocrinology. 157:2403–2415. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H and Kangawa K: Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 294:H426–H432. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr, Baptista MJ, Lourenço AP, Oliveira SM, Brandão-Nogueira A, Teles A, Fortunato JM and Leite-Moreira AF: Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 287:H2885–H2890. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS and Wang P: Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 176:805–813. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, et al: Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 148:3004–3012. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Andersson M, Iresjö BM, Lönnroth C and Lundholm K: Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol. 28:1393–1400. 2006.PubMed/NCBI | |
|
Bayliss JA, Lemus MB, Stark R, Santos VV, Thompson A, Rees DJ, Galic S, Elsworth JD, Kemp BE, Davies JS and Andrews ZB: Ghrelin-AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson's disease. J Neurosci. 36:3049–3063. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Unger MM, Oertel WH and Tackenberg B: Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis. Neuro Endocrinol Lett. 34:14–17. 2013.PubMed/NCBI | |
|
Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CM, Woodruff TM, O'Sullivan JD, Henderson RD and McCombe PA: Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci. 357:22–27. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cassoni P, Ghé C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M and Muccioli G: Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol. 150:173–184. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Grönberg M, Fjällskog ML, Jirström K and Janson ET: Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Acta Oncol. 51:386–393. 2012. View Article : Google Scholar | |
|
Sadjadi A, Yazdanbod A, Lee YY, Boreiri M, Samadi F, Alizadeh BZ, Islami F, Fyfe V, Babaei M, Namazi MJ, et al: Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. PLoS One. 8:e744402013. View Article : Google Scholar : PubMed/NCBI | |
|
Lin TC, Liu YP, Chan YC, Su CY, Lin YF, Hsu SL, Yang CS and Hsiao M: Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis. J Pathol. 237:50–61. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
De Vriese C and Delporte C: Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells. J Endocrinol. 192:199–205. 2007. View Article : Google Scholar | |
|
Cassoni P, Papotti M, Ghè C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E and Muccioli G: Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 86:1738–1745. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tsubouchi H, Onomura H, Saito Y, Yanagi S, Miura A, Matsuo A, Matsumoto N and Nakazato M: Ghrelin does not influence cancer progression in a lung adenocarcinoma cell line. Endocr J. 64 (Suppl 1):S41–S46. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Duxbury MS, Waseem T, Ito H, Robinson MK, Zinner MJ, Ashley SW and Whang EE: Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun. 309:464–468. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Jeffery PL, Herington AC and Chopin LK: Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol. 172:R7–R11. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tian C, Zhang L, Hu D and Ji J: Ghrelin induces gastric cancer cell proliferation, migration, and invasion through GHS-R/NF-κB signaling pathway. Mol Cell Biochem. 382:163–172. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam M and Qureshi MA: Role of ghrelin axis in colorectal cancer: A novel association. Peptides. 29:1369–1376. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lien GS, Lin CH, Yang YL, Wu MS and Chen BC: Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways. Eur J Pharmacol. 776:124–131. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kraus D, Reckenbeil J, Wenghoefer M, Stark H, Frentzen M, Allam JP, Novak N, Frede S, Götz W, Probstmeier R, et al: Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. Cell Mol Life Sci. 73:1287–1299. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Waseem T, Duxbury M, Ashley SW and Robinson MK: Ghrelin promotes intestinal epithelial cell proliferation through PI3K/Akt pathway and EGFR trans-activation both converging to ERK 1/2 phosphorylatio. Peptides. 52:113–121. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K and Palù G: Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology. 68:414–421. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fung JN, Seim I, Wang D, Obermair A, Chopin LK and Chen C: Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm Cancer. 1:245–255. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lawnicka H, Mełeń-Mucha G, Motylewska E, Mucha S and Stępień H: Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro. Pharmacol Rep. 64:951–959. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
El-Kott AF, Shati AA, Al-Kahtani MA and Alqahtani S: Acylated ghrelin renders chemosensitive ovarian cancer cells resistant to cisplatin chemotherapy via activation of the PI3K/Akt/mTOR survival pathway. Anal Cell Pathol (Amst). 2019:96278102019.PubMed/NCBI | |
|
Rincón-Fernández D, Culler MD, Tsomaia N, Moreno-Bueno G, Luque RM, Gahete MD and Castaño JP: In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines. Carcinogenesis. 39:447–457. 2018. View Article : Google Scholar | |
|
Hormaechea-Agulla D, Gahete MD, Jiménez-Vacas JM, Gómez-Gómez E, Ibáñez-Costa A, L-López F, Rivero-Cortés E, Sarmento-Cabral A, Valero-Rosa J, Carrasco-Valiente J, et al: The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Mol Cancer. 16:1462017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JH, Huang SM, Chen CC, Tsai CF, Yeh WL, Chou SJ, Hsieh WT and Lu DY: Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells. J Cell Biochem. 112:2931–2941. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lin TC, Yeh YM, Fan WL, Chang YC, Lin WM, Yang TY and Hsiao M: Ghrelin upregulates oncogenic Aurora A to promote renal cell carcinoma invasion. Cancers (Basel). 11:3032019. View Article : Google Scholar : PubMed/NCBI | |
|
Tiaka EK, Manolakis AC, Kapsoritakis AN and Potamianos SP: Unraveling the link between leptin, ghrelin and different types of colitis. Ann Gastroenterol. 24:20–28. 2011.PubMed/NCBI | |
|
Ghomraoui FA, Alotaibi ST, Alharthi MA, Asiri SS, Almadi MA, Alharbi OR, Azzam NA, Aljebreen AM, Saeed M, Hajkhder B, et al: Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status. Saudi J Gastroenterol. 23:199–205. 2017.PubMed/NCBI | |
|
Omoto I, Matsumoto M, Uchikado Y, Kita Y, Sakurai T, Sasaki K, Setoyama T, Okumura H, Owaki T, Ishigami S and Natsugoe S: Immunohistochemical evidence of association between ghrelin expression and tumor growth in esophageal carcinoma. Anticancer Res. 34:2727–2733. 2014.PubMed/NCBI | |
|
Mottershead M, Karteris E, Barclay JY, Suortamo S, Newbold M, Randeva H and Nwokolo CU: Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma. J Clin Pathol. 60:405–409. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Murphy G, Kamangar F, Albanes D, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Dawsey SM and Freedman ND: Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut. 61:1533–1537. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pritchett NR, Maziarz M, Shu XO, Kamangar F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL, et al: Serum ghrelin and esophageal and gastric cancer in two cohorts in China. Int J Cancer. 146:2728–2735. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
de Martel C, Haggerty TD, Corley DA, Vogelman JH, Orentreich N and Parsonnet J: Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol. 102:1166–1172. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas SJ, Almers L, Schneider J, Graham JE, Havel PJ and Corley DA: Ghrelin and leptin have a complex relationship with risk of Barrett's esophagus. Dig Dis Sci. 61:70–79. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rubenstein JH, Morgenstern H, McConell D, Scheiman JM, Schoenfeld P, Appelman H, McMahon LF Jr, Kao JY, Metko V, Zhang M and Inadomi JM: Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterolog. 145:1237–1244.e1-e5. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Konturek PC, Burnat G, Rau T, Hahn EG and Konturek S: Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci. 53:597–605. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Xie SH, Rabbani S, Ness-Jensen E and Lagergren J: Circulating levels of inflammatory and metabolic biomarkers and risk of esophageal adenocarcinoma and Barrett esophagus: Systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 29:2109–2118. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu C, Liu Y, Kang W, Zhang Z, Zeng Z and Liu D: Exploration of the role of serum ghrelin in the diagnosis and treatment of digestive tract malignancies. J Int Med Res. 48:3000605209204412020. View Article : Google Scholar : PubMed/NCBI | |
|
Shinsyu A, Bamba S, Kurihara M, Matsumoto H, Sonoda A, Inatomi O, Andoh A, Takebayashi K, Kojima M, Iida H, et al: Inflammatory cytokines, appetite-regulating hormones, and energy metabolism in patients with gastrointestinal cancer. Oncol Lett. 20:1469–1479. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, Chen CQ, He YL and Cai SR: Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 23:6261–6272. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW: Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Aydin S, Ozercan IH, Dagli F, Aydin S, Dogru O, Celebi S, Akin O and Guzel SP: Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech Histochem. 80:163–168. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
An JY, Choi MG, Noh JH, Sohn TS, Jin DK and Kim S: Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res. 143:344–349. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Murphy G, Kamangar F, Dawsey SM, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Albanes D and Freedman ND: The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst. 103:1123–1129. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nwokolo CU, Freshwater DA, O'Hare P and Randeva HS: Plasma ghrelin following cure of Helicobacter pylori. Gut. 52:637–640. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y and Sugano K: Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab. 90:10–16. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zub-Pokrowiecka A, Rembiasz K, Konturek PC, Budzyński A, Konturek SJ, Winiarski M and Bielański W: Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy. World J Gastroenterol. 17:449–458. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH and Sim MS: Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab. 89:5392–5396. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Takachi K, Doki Y, Ishikawa O, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K, et al: Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 130:1–7. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Wu Y, Ye B, Wu F and Wang P: High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients. Medicine (Baltimore). 99:e206352020. View Article : Google Scholar : PubMed/NCBI | |
|
Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B and Shimon I: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 106:966–973. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu A, Huang C, Xu J and Cai X: Lentivirus-mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells. Cancer Med. 5:2417–2426. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Q, Fan YZ, Ge BJ, Zhu Q and Tu ZY: Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci. 52:803–809. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S, Marinello E and Vannoni D: Circulating gastrin and ghrelin levels in patients with colorectal cancer: Correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother. 61:137–141. 2007. View Article : Google Scholar | |
|
Nikolopoulos D, Theocharis S, Moutsios-Rentzos A, Kouraklis G and Kostakis A: The role of serum total ghrelin level elevation in colon cancer patients. J BUON. 19:388–393. 2014.PubMed/NCBI | |
|
Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, Demiriz B and Tuzun S: The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol. 8:852010. View Article : Google Scholar : PubMed/NCBI | |
|
Murphy G, Cross AJ, Dawsey SM, Stanczyk FZ, Kamangar F, Weinstein SJ, Taylor PR, Männistö S, Albanes D, Abnet CC and Freedman ND: Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study. Gut. 67:1646–1651. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sundkvist A, Myte R, Palmqvist R, Harlid S and Van Guelpen B: Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer. Gut. 68:373–374. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Coppedè F, Stoccoro A, Lazzarotti A, Spisni R and Migliore L: Investigation of GHSR and GHRL methylation in colorectal cancer. Epigenomics. 10:1525–1539. 2018. View Article : Google Scholar | |
|
Chopin LK, Seim I, Walpole CM and Herington AC: The ghrelin axis-does it have an appetite for cancer progression? Endocr Rev. 33:849–891. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Molfino A, Formiconi A, Rossi Fanelli F and Muscaritoli M: Ghrelin: From discovery to cancer cachexia therapy. Curr Opin Clin Nutr Metab Care. 17:471–476. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rindi G, Savio A, Torsello A, Zoli M, Locatelli V, Cocchi D, Paolotti D and Solcia E: Ghrelin expression in gut endocrine growths. Histochem Cell Biol. 117:521–525. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G and Ghigo E: Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab. 86:5052–5059. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Raffel A, Krausch M, Cupisti K, Gerharz CD, Eisenberger CF and Knoefel WT: Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1. Horm Metab Res. 37:653–655. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ekeblad S, Nilsson B, Lejonklou MH, Johansson T, Stålberg P, Nilsson O, Ahlman H and Skogseid B: Gastrointestinal stromal tumors express the orexigen ghrelin. Endocr Relat Cancer. 13:963–970. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Volante M, Allìa E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E and Papotti M: Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab. 87:1300–1308. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ekeblad S, Lejonklou MH, Grimfjärd P, Johansson T, Eriksson B, Grimelius L, Stridsberg M, Stålberg P and Skogseid B: Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin Endocrinol (Oxf). 66:115–122. 2007.PubMed/NCBI | |
|
Tsolakis AV, Stridsberg M, Grimelius L, Portela-Gomes GM, Falkmer SE, Waldum HL and Janson ET: Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration. J Clin Gastroenterol. 42:381–388. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Walter T, Chardon L, Hervieu V, Cohen R, Chayvialle JA, Scoazec JY and Lombard-Bohas C: Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: Report of three cases. Eur J Endocrino. 161:639–645. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Corbetta S, Peracchi M, Cappiello V, Lania A, Lauri E, Vago L, Beck-Peccoz P and Spada A: Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: Identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab. 88:3117–3120. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wang HS, Oh DS, Ohning GV and Pisegna JR: Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors. J Mol Neurosci. 33:225–231. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
van Adrichem RC, van der Lely AJ, Huisman M, Kramer P, Feelders RA, Delhanty PJ and de Herder WW: Plasma acylated and plasma unacylated ghrelin: Useful new biomarkers in patients with neuroendocrine tumors? Endocr Connect. 5:143–151. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Luque RM, Sampedro-Nuñez M, Gahete MD, Ramos-Levi A, Ibáñez-Costa A, Rivero-Cortés E, Serrano-Somavilla A, Adrados M, Culler MD, Castaño JP and Marazuela M: In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters. Oncotarget. 6:19619–19633. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Herrera-Martínez AD, Gahete MD, Sánchez-Sánchez R, Alors-Perez E, Pedraza-Arevalo S, Serrano-Blanch R, Martínez-Fuentes AJ, Gálvez-Moreno MA, Castaño JP and Luque RM: Ghrelin-O-acyltransferase (GOAT) enzyme as a novel potential biomarker in gastroenteropancreatic neuroendocrine tumors. Clin Transl Gastroenterol. 9:1962018. View Article : Google Scholar | |
|
Hirota S: Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry. Transl Gastroenterol Hepatol. 3:272018. View Article : Google Scholar : PubMed/NCBI | |
|
Doyle LA and Hornick JL: Gastrointestinal stromal tumours: From KIT to succinate dehydrogenase. Histopathology. 64:53–67. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu CZ, Liu D, Kang WM, Yu JC, Ma ZQ, Ye X and Li K: Ghrelin and gastrointestinal stromal tumors. World J Gastroenterol. 23:1758–1763. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ghè C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, Muccioli G and Papotti M: The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology. 143:484–491. 2002. View Article : Google Scholar | |
|
Alnema MM, Aydin S, Ozkan Y, Dagli AF, Ozercan HI, Yildirim N, Sahin I, Karaoglu A, Kilic N, Yilmaz M, et al: Ghrelin and obestatin expression in oral squamous cell carcinoma: An immunohistochemical and biochemical study. Mol Cell Biochem. 339:173–179. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lou J, Liu L, Zhang W, Zhou Z and Fan Y: Differential expression of ghrelin and GHSR via the mTOR pathway during the dynamic carcinogenic process involving oral, potentially malignant disorders. Biosci Rep. 39:BSR201921022019. View Article : Google Scholar : PubMed/NCBI | |
|
Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH and Ozercan MR: Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol Res Pract. 205:165–173. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Grönberg M, Amini RM, Stridsberg M, Janson ET and Saras J: Neuroendocrine markers are expressed in human mammary glands. Regul Pept. 160:68–74. 2010. View Article : Google Scholar | |
|
Grönberg M, Nilsson C, Markholm I, Hedenfalk I, Blomqvist C, Holmberg L, Tiensuu Janson E and Fjällskog ML: Ghrelin expression is associated with a favorable outcome in male breast cancer. Sci Rep. 8:135862018. View Article : Google Scholar | |
|
Malendowicz W, Ziolkowska A, Szyszka M and Kwias Z: Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urol Int. 83:471–475. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fung JN, Jeffery PL, Lee JD, Seim I, Roche D, Obermair A, Chopin LK and Chen C: Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo. Am J Physiol Endocrinol Metab. 305:E305–E313. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P and Gourgoulianis KI: Clinical significance of serum adipokines levels in lung cancer. Med Oncol. 30:5072013. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Zhao X, Li C, Liu S, Yan F, Teng Y, Feng J and Miao D: Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer. Hum Cell. 32:360–366. 2019. View Article : Google Scholar : PubMed/NCBI |
